Meghan Morrissey is a marketing professional with a knack for launching new products in the biopharmaceutical and e-clinical technology industries. She has a solid track record in the field, with stints at Alexion Pharmaceuticals, Inc., Synageva BioPharma Corp., PharmaVigilant, and SLN Marketing Communications. Morrissey is well-versed in rare disease marketing, strategic planning, and global commercial strategy development. She is currently pursuing a Master of Liberal Arts degree in Extension Studies, majoring in Management at Harvard University.